Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.
Liu Y, Zhao Y, Shukha Y, Lu H, Wang L, Liu Z, Liu C, Zhao Y, Wang H, Zhao G, Liang W, Fan Y, Chang L, Yurdagul A Jr, Pattillo CB, Orr AW, Aviram M, Wen B, Garcia-Barrio MT, Zhang J, Liu W, Sun D, Hayek T, Chen YE, Rom O.
Liu Y, et al. Among authors: orr aw.
Cell Rep. 2021 Jul 27;36(4):109420. doi: 10.1016/j.celrep.2021.109420.
Cell Rep. 2021.
PMID: 34320345
Free PMC article.